
Category
Antitussive / Cough Suppressant
Form
Tablets
Strength
As per dossier (verify)
CAS
70132-12-4 (verify)
Prenoxdiazine HCl Tablets – Advanced Dry Cough Suppression Therapy
Peripheral antitussive mechanism. Effective for dry, non-productive cough. Non-sedative cough relief profile. Targeted respiratory symptom control. Manufactured under global pharmaceutical standards.
Prenoxdiazine HCl Tablets by LARKSOIS Pharma are designed for managing dry, irritating cough. Classified under ATC code R05DB18. Provide symptomatic relief without heavy sedation. Suitable for respiratory conditions involving non-productive cough. Manufactured under strict international standards.
Request QuoteOverview
- Prenoxdiazine HCl Tablets provide targeted dry cough relief.
- Belong to the antitussive class of medications.
- Act peripherally to suppress cough reflex.
- Used for respiratory irritation without mucus.
- Ensure effective and controlled symptom relief.
Introduction
- Prenoxdiazine HCl Tablets by LARKSOIS Pharma are designed for managing dry, irritating cough.
- Classified under ATC code R05DB18.
- Provide symptomatic relief without heavy sedation.
- Suitable for respiratory conditions involving non-productive cough.
- Manufactured under strict international standards.
Important Information
- Antitussive for dry, non-productive cough.
- Not an antifungal medication.
- Acts on peripheral cough receptors.
- Short-term symptomatic therapy.
- Requires medical supervision for prolonged use.
Dosage
General
- Dosage as per physician guidance
- Depends on approved product strength
- Short-term therapy recommended
Administration
- Take orally with water
- Swallow tablets whole
- Maintain consistent dosing schedule
- Do not exceed recommended dose
Important
- Use only under medical supervision
- Do not use long-term without evaluation
- Follow prescribed duration strictly
Storage
- Store in a cool, dry place
- Protect from heat and moisture
- Keep in original packaging
- Keep out of reach of children
Shelf Life
- Shelf life as per stability data
- Refer to packaging for expiry
- Do not use expired product
Manufacturing
- Manufactured under GMP-compliant facilities
- Controlled tablet production processes
- High-quality API sourcing
- Strict quality control systems
- Aligned with international pharmaceutical standards
Precautions
- Use cautiously in elderly patients
- Avoid in hypersensitivity cases
- Not recommended for productive cough with mucus
- Use in pregnancy/lactation under medical advice
- Avoid prolonged use without evaluation
- Monitor persistent cough symptoms
Side Effects
- Nausea
- Constipation
- Dry mouth
- Allergic reactions
- Skin rash
- Bronchospasm (rare)
- Fatigue (overdose)
Expert View
- Effective peripheral cough suppressant.
- Non-sedative respiratory therapy option.
- Ideal for dry cough management.
- Widely used in respiratory care.
- Reliable symptom control.
Indications
- Dry, non-productive cough
- Cough associated with bronchitis
- Pharyngitis-related cough
- Asthma-related dry cough
- Respiratory irritation
- Pre-procedure cough suppression
Maintenance
- Short-term use recommended
- Monitor symptom improvement
- Avoid long-term unsupervised use
- Consult physician if cough persists
- Follow prescribed treatment duration
Why Choose
- Peripheral antitussive mechanism
- Non-sedative cough relief
- Targeted dry cough control
- Short-course therapy suitability
- Globally aligned pharmaceutical quality
Frequently Asked Questions
Common product and supply questions.
What is prenoxdiazine used for?+-
Prenoxdiazine HCl Tablets are used for the symptomatic relief of dry, non-productive cough by reducing cough reflex sensitivity.
What are the side effects of prenoxdiazine?+-
Common side effects include nausea, constipation, dry mouth, and mild allergic reactions, while rare cases may involve bronchospasm.
Is prenoxdiazine addictive?+-
Prenoxdiazine is not classified as an addictive medication and is considered a non-opioid antitussive.
What is the mechanism of action of prenoxdiazine?+-
It works by reducing cough impulses through peripheral receptor desensitization in the respiratory tract.
What is the classification of prenoxdiazine?+-
Prenoxdiazine is classified as an antitussive or cough suppressant under ATC code R05DB18.
